- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT00271908
C2P (With Venues): Connect to Protect® Partnerships For Youth Prevention Interventions
Connect to Protect® Partnerships for Youth Prevention Interventions Phase III: Full Evaluation
Tutkimuksen yleiskatsaus
Yksityiskohtainen kuvaus
Phase III's objective is to initiate and complete a community mobilization intervention aimed at reducing HIV incidence and prevalence among youth. The intervention will consist of guiding C2P coalitions through a strategic planning process that will result in the development and implementation of a local action plan. The action plan will focus on changing structural elements of the affected communities that are believed to be associated with youth HIV acquisition and transmission. The effectiveness of the intervention will be evaluated by tracking venues where the population of interest congregates and trends in risk factors associated with HIV acquisition and transmission.
ATN 040b evaluates annual anonymous data collection of two cohorts per participating ATN/C2P site. Both cohorts will represent a site's population of focus, but will be recruited in different ways and for different activities.
Cohort #1 will be referred to the site via Official Community Partners and word of mouth. Each year of the study, 10 to 20 individuals will be recruited to complete venue-tracking surveys as described in Section 2.1 (N = 40-80 per site over four years). The results will either confirm that the population of focus can still be reached at previously identified congregation venues or reveal new ones that should be considered for further research activities. Each year, based on data from Cohort #1, ATN/C2P site staff will go to two to three of the confirmed and/or new congregation venues to recruit 20 to 30 participants per venue for Cohort #2. These participants will complete the HIV-related risk survey, with the addition of the HIV-Ab assay in the final year only (N = 160-360 per site over four years). Data will be used to evaluate the intervention within and across ATN/C2P sites.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
San Juan, Puerto Rico, 00936
- University Pediatric Hospital
-
-
-
-
California
-
Los Angeles, California, Yhdysvallat, 90054
- Childrens Hospital of Los Angeles
-
San Francisco, California, Yhdysvallat, 94143
- University of California at San Francisco
-
-
District of Columbia
-
Washington, District of Columbia, Yhdysvallat, 20010
- Childrens Hospital National Medical Center
-
-
Florida
-
Tampa, Florida, Yhdysvallat, 33606
- University of South Florida
-
-
Illinois
-
Chicago, Illinois, Yhdysvallat, 60612
- Stroger Hospital of Cook County
-
-
Maryland
-
Baltimore, Maryland, Yhdysvallat, 21201
- University of Maryland
-
-
New York
-
New York, New York, Yhdysvallat, 10128
- Mount Sinai Medical Center
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Näytteenottomenetelmä
Tutkimusväestö
Kuvaus
Inclusion Criteria:
- An individual who provides verbal confirmation that his or her age falls within the range of the site's population of focus (which must be within 12 through 24 years, inclusive);
- Verbal confirmation of demographic and sexual orientation/experience profile reflective of the site's population of focus;
- Must report engaging in any voluntary sexual activity (vaginal, anal or oral sex) within the past 12 months, regardless of sexual abuse history; and
- Ability to understand and willingness to provide verbal informed consent/assent in English or Spanish.
Exclusion Criteria:
- Visibly distraught and/or visibly emotionally unstable (e.g., depressive mood; exhibiting manic, suicidal, or violent behavior);*
- Visibly intoxicated or under the influence of psychoactive agents#; or
Presents as acutely ill.
Although it is very unlikely that an individual from the community will overtly show signs of suicidality, youth with any of these exclusion criteria may be approached at a later date if encountered again at the venue and earlier exclusionary conditions are resolved.
- For sites targeting drug users, this may pose challenges. Potential participants who are visibly under the influence are to be further assessed in terms of their level of alertness, coherency, and abilities to understand and respond to questions. This is to be done keeping staff and participant safety in mind, as well as follow-up procedures such as providing service referrals.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Havaintomallit: Kohortti
- Aikanäkymät: Poikkileikkaus
Kohortit ja interventiot
Ryhmä/Kohortti |
Interventio / Hoito |
|---|---|
|
Cohort #1
Venue-tracking survey subjects recruited annually for 4 years: N= 320-640 (10-20 members of the population of focus per site, per year).
The purpose of this cohort is to identify and track venues at which the population of focus congregates.
|
ATN 040b is the evaluation sub-study for ATN 040, Phase III of C2P.
Phase III is a community mobilization intervention aimed at reducing HIV rates among youth via community structural change.
ATN 040b involves annual anonymous data collection with two cohorts per participating ATN/C2P site.
Both cohorts will represent the site's target population, or "population of focus."
Muut nimet:
|
|
Cohort #2
HIV-related risk survey subjects recruited annually for 4 years: N = 1280-2880 (20-30 members of the population of focus per 2-3 congregation venues, per site, per year).
These subjects will complete a survey designed to assess HIV-related risk.
In the fourth and final year only, HIV Antibody [Ab] assays will also be conducted with survey participants to assess HIV serostatus.
The survey and HIVAb assay data will be used to evaluate the intervention within and across sites.
|
ATN 040b is the evaluation sub-study for ATN 040, Phase III of C2P.
Phase III is a community mobilization intervention aimed at reducing HIV rates among youth via community structural change.
ATN 040b involves annual anonymous data collection with two cohorts per participating ATN/C2P site.
Both cohorts will represent the site's target population, or "population of focus."
Muut nimet:
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Collect data that will be used to evaluate the overall efficacy of the community mobilization intervention
Aikaikkuna: 4 years
|
The aim of ATN 040b is to collect data that will be used to evaluate the overall efficacy of the community mobilization intervention and to assess changes in HIV-related risks over time.
|
4 years
|
Yhteistyökumppanit ja tutkijat
Yhteistyökumppanit
Tutkijat
- Opintojen puheenjohtaja: Jonathan Ellen, MD, Johns Hopkins University
Julkaisuja ja hyödyllisiä linkkejä
Hyödyllisiä linkkejä
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- ATN 040b
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset HIV-infektiot
-
Bactiguard ABKarolinska University HospitalValmisLeikkaus | Central Line Associated Blood Stream Infections (CLABSI)Ruotsi
-
Rabin Medical CenterRekrytointiCentral-line Associated Blood Stream Infections (CLABSI)Israel
-
Emory UniversityValmisCentral Line Associated Bloodstream Infections (CLABSI) | LuuydinsiirtoYhdysvallat
-
Swedish Medical CenterProvidence Health & ServicesRekrytointiCentral Line Associated Blood Stream Infections (CLABSI)Yhdysvallat
-
CorMedixRekrytointiCentral Line Associated Blood Stream Infections (CLABSI)Yhdysvallat, Turkki (Türkiye)
-
Hiroshima UniversityEi vielä rekrytointiaHengityslaitteen hankittu keuhkokuume | Central Line Associated Blood Stream Infections (CLABSI) | Painehaava (PU) | Lääkinnällisen laitteen aiheuttama painohaava (MDRPU)Bangladesh, Japani
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRekrytointiHIV | HIV-testaus | HIV-yhteys hoitoon | HIV-hoitoYhdysvallat
-
Federal University of São PauloGilead SciencesValmis
-
University of Alabama at BirminghamNational Institute of Mental Health (NIMH)RekrytointiPrEP | HIV | HIV-ehkäisy | PrEP-ottoYhdysvallat
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RekrytointiHIV-ehkäisy | PrEP-kiinnitys | HIV-liittyvä stigmaThaimaa
Kliiniset tutkimukset Community Mobilization
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH); Aurum InstituteValmisHiv | Sitoutuminen, kärsivällinenEtelä-Afrikka
-
University of California, Los AngelesValmis
-
Icahn School of Medicine at Mount SinaiRekrytointiBurnout, psykologinen | Stressi, psykologinen | Resilienssi, psykologinenYhdysvallat
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); Florida State University; Autism...ValmisAutismin kirjon häiriötYhdysvallat
-
José Ignacio Recio RodriguezGerencia Regional de Salud de Castilla y Leon; Consejo General de Colegios... ja muut yhteistyökumppanitEi vielä rekrytointiaMonimutkainen ja krooninen pluripatologia
-
Boston University Charles River CampusMental Health Center of Denver; Connecticut State, Department of Mental... ja muut yhteistyökumppanitValmis
-
Sarah MacLeishNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); KeborM...Aktiivinen, ei rekrytointi
-
University of CalgaryUniversity of AlbertaValmisHypertensio | Diabetes mellitus, tyyppi 2 | Krooniset munuaissairaudet | Krooninen keuhkoahtaumatauti | Astma | Iskeeminen sydänsairaus | Sydämen vajaatoimintaKanada
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); University of Pittsburgh ja muut yhteistyökumppanitAktiivinen, ei rekrytointi
-
University of CalgaryValmisHypertensio | Diabetes mellitus, tyyppi 2 | Krooniset munuaissairaudet | Krooninen keuhkoahtaumatauti | Astma | Iskeeminen sydänsairaus | Sydämen vajaatoimintaKanada